Profiel
Einar Pontén is currently the Head-Business Development at Lipum AB since 2016.
Previously, he worked as the Managing Director at Merck SeQuant AB and as the Head-Research & Development at Anolytech AB. Dr. Pontén holds a doctorate degree from Umea Universitet.
Actieve functies van Einar Pontén
| Bedrijven | Functie | Begin |
|---|---|---|
| LIPUM AB | Corporate Officer/Principal | 01-12-2023 |
Eerdere bekende functies van Einar Pontén
| Bedrijven | Functie | Einde |
|---|---|---|
Merck SeQuant AB
Merck SeQuant AB Medical SpecialtiesHealth Technology Provides liquid chromatography technology and other related products | Algemeen Directeur | 02-01-2011 |
Anolytech AB
Anolytech AB Wholesale DistributorsDistribution Services Provides disinfection of livestock farming and food production solutions | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Einar Pontén
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Merck SeQuant AB
Merck SeQuant AB Medical SpecialtiesHealth Technology Provides liquid chromatography technology and other related products | Health Technology |
Umea Universitet
Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anolytech AB
Anolytech AB Wholesale DistributorsDistribution Services Provides disinfection of livestock farming and food production solutions | Distribution Services |
Lipum AB
Lipum AB BiotechnologyHealth Technology Develops biological anti-inflammatory drugs | Health Technology |
















